(4R,7S,10S,13R,16S,19R)-24-amino-13-benzyl-10-[3-(diaminomethylideneamino)propyl]-16-(1H-imidazol-5-ylmethyl)-7-(1H-indol-3-ylmethyl)-19-methyl-6,9,12,15,18,21-hexaoxo-2-thia-5,8,11,14,17,20-hexazabicyclo[20.4.0]hexacosa-1(22),23,25-triene-4-carboxamide

InChIKey	`YBKZXQIAHZXKIW-IMAQRSJWSA-N`
Compound Name	(4R,7S,10S,13R,16S,19R)-24-amino-13-benzyl-10-[3-(diaminomethylideneamino)propyl]-16-(1H-imidazol-5-ylmethyl)-7-(1H-indol-3-ylmethyl)-19-methyl-6,9,12,15,18,21-hexaoxo-2-thia-5,8,11,14,17,20-hexazabicyclo[20.4.0]hexacosa-1(22),23,25-triene-4-carboxamide
Canonical SMILES	`C[C@H]1NC(=O)c2cc(N)ccc2SC[C@@H](C(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC1=O`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	3
Pfam Stratification	Homologous
Avg pChEMBL	8.38
Source	ChEMBL

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P32245	MC4R	Homo sapiens	Human	PF00001	9.8	Ki	ChEMBL
Q01726	MC1R	Homo sapiens	Human	PF00001	8.3	Ki	ChEMBL
P41968	MC3R	Homo sapiens	Human	PF00001	7.0	Ki	ChEMBL